The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
COMy 2022 | Highlights and debates at COMy 2022
In this video, Sagar Lonial, MD, FACP, Winship Cancer Institute of Emory University, Atlanta, GA, briefly discusses the debate around using measurable residual disease (MRD) to guide treatment in multiple myeloma and the importance of upcoming clinical trials in answering questions in this field. This interview took place at the 8th World Congress on Controversies in Multiple Myeloma (COMy) 2022, held in Paris, France.
